2. Academic Validation
  3. Discovery of Michael acceptor containing 1,4-dihydropyridines as first covalent inhibitors of L-/T-type calcium channels

Discovery of Michael acceptor containing 1,4-dihydropyridines as first covalent inhibitors of L-/T-type calcium channels

  • Bioorg Chem. 2019 Oct:91:103187. doi: 10.1016/j.bioorg.2019.103187.
Hande Aygün Cevher 1,  David Schaller 2,  Maria A Gandini 3,  Ozan Kaplan 4,  Eder Gambeta 3,  Fang Xiong Zhang 3,  Mustafa Çelebier 4,  Muhammad Nawaz Tahir 5,  Gerald W Zamponi 3,  Gerhard Wolber 2,  Miyase Gözde Gündüz 6
Affiliations

Affiliations

  • 1 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, 06100 Sıhhiye, Ankara, Turkey.
  • 2 Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Str. 2+4, 14195 Berlin, Germany.
  • 3 Department of Physiology & Pharmacology, Hotchkiss Brain Institute and Alberta Children's Hospital Research Institute, University of Calgary, 3330 Hospital Drive NW, Calgary T2N 4N1, Canada.
  • 4 Department of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, 06100 Sıhhiye, Ankara, Turkey.
  • 5 Department of Physics, University of Sargodha, Sargodha, Pakistan.
  • 6 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, 06100 Sıhhiye, Ankara, Turkey. Electronic address: miyasegunduz@yahoo.com.
PMID: 31419643 DOI: 10.1016/j.bioorg.2019.103187
Abstract

1,4-Dihydropyridines (DHPs) are an important class of blockers targeting different Calcium Channel subtypes and have great therapeutic value against cardiovascular and neurophysiologic conditions. Here, we present the design of DHP-based hexahydroquinoline derivatives as either selective or covalent inhibitors of calcium channels. These compounds were synthesized via a modified Hantzsch reaction under microwave irradiation and characterized by IR, 1H NMR, 13C NMR and mass spectra. Additionally, the proposed structure of HM12 was resolved by single crystal X-ray analysis. The abilities of the target compounds to block both L- and T-type calcium channels were evaluated by utilizing the whole-cell patch clamp technique. Our results identified covalent inhibitors of calcium channels for the first time, which could be achieved by introducing a Michael acceptor group into the ester side chain of the compounds. The proposed covalent binding between the compounds and the cysteine amino acid (Cys1492) within the DHP binding pocket of L-type calcium channel was supported by docking and pharmacophore analysis as well as a glutathione reactivity assay.

Keywords

Calcium channel blocker; Covalent binding; Dihydropyridine; Hexahydroquinoline; Molecular modeling; Whole-cell patch clamp.

Figures
Products